Collplant Biotechnologies Ltd (CLGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $14.27M
Last updated: Nov 16, 2026 at 4:00 PM ET
Collplant Biotechnologies Ltd (CLGN) Stock Chart
Collplant Biotechnologies (CLGN) closed at $4.64 on Nov 16, 2026, 79.4% below its 52-week high of $22.50. Its price fell 76.6% over the past 12 months. The month-end price fell 95.4% since Jan 2018, a compound annual decline of 29.6%.
Price Chart
From Jan 2018 to Oct 2026, its highest month-end close was $220.00 in Oct 2021 and its lowest $2.73 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CLGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 47.6%, and over 6 months it rose 6.7%. The month-end price fell 92.3% over the 3 years through Oct 2026, a compound annual decline of 57.4%.
| Period | Change |
|---|---|
| 1 month | +28.0% |
| 3 months | +47.6% |
| 6 months | +6.7% |
| 12 months | -76.6% |
| 12 months, with dividends | -76.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -92.3% | -57.4% |
| 5 years | -98.1% | -54.8% |
| Since Jan 2018 | -95.4% | -29.6% |
Price by Year
Its best calendar year was 2020, when the price rose 88.9%, and its weakest was 2025, when it fell 61.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.13 | -70.5% |
| 2025 | $14.00 | -61.1% |
| 2024 | $36.00 | -43.7% |
| 2023 | $63.90 | -23.5% |
| 2022 | $83.50 | -49.0% |
| 2021 | $163.60 | +51.9% |
| 2020 | $107.70 | +88.9% |
| 2019 | $57.00 | +35.7% |
Trading Range
The price is 19.4% above its 50-day average of $3.89 and 5.6% above its 200-day average of $4.40.
| Measure | Value | Price vs |
|---|---|---|
| Close (Nov 16, 2026) | $4.64 | |
| 52-week high | $22.50 | -79.4% |
| 52-week low | $2.64 | +76.0% |
| 50-day average | $3.89 | +19.4% |
| 200-day average | $4.40 | +5.6% |
Price Risk
Over 3 years, its largest fall from a peak was 96.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.39 |
| Largest fall, 1 year | -87.8% |
| Largest fall, 3 years | -96.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CLGN
What is CLGN's 1-year price change?
Collplant Biotechnologies's price fell 76.6% over the past 12 months. With dividends included, the 12-month total return was -76.6%.
What is CLGN's 5-year price change?
Collplant Biotechnologies's month-end price fell 98.1% over the 5 years through Oct 2026, a compound annual decline of 54.8%. These figures leave out dividends.
What is CLGN's 52-week high and low?
Collplant Biotechnologies's 52-week high is $22.50 and its 52-week low is $2.64. Its close of $4.64 on Nov 16, 2026 is 79.4% below the high.
What is CLGN's beta?
Collplant Biotechnologies's 1-year beta against the S&P 500 is 1.39, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.8%.
Is the CLGN chart free?
Yes. Advanced Charting for CLGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CLGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors